These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1199726

  • 1. Light and electron microscopic studies of the bone marrow and blood cells in chronic panmyelosis including polycythemia vera and primary thrombocythemia.
    Nagai K, Kamata Y, Kimura M, Chiba Y.
    Acta Pathol Jpn; 1975 Sep; 25(5):517-37. PubMed ID: 1199726
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J, Funke S, Holgado S, Choritz H, Georgii A.
    Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
    [Abstract] [Full Text] [Related]

  • 4. Megakaryocyte precursors (pro- and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera and primary (essential) thrombocythemia. An immunomorphometric study.
    Thiele J, Wagner S, Degel C, Dienemann D, Wienhold S, Zankovich R, Fischer R, Stein H.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990 Sep; 58(4):295-302. PubMed ID: 1970693
    [Abstract] [Full Text] [Related]

  • 5. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983 Sep; 67():214-75. PubMed ID: 6666266
    [No Abstract] [Full Text] [Related]

  • 6. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
    Bobik R, Podolak-Dawidziak M, Kiełbiński M, Jeleń M, Wróbel T.
    Acta Haematol Pol; 1995 Sep; 26(2):179-83. PubMed ID: 7653223
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M.
    Acta Haematol Pol; 1992 Sep; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract] [Full Text] [Related]

  • 10. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N, Stacher E, Regitnig P, Zinke-Cerwenka W, Hojas S, Hubmann E, Porwit A, Bjorkholm M, Hoefler G, Beham-Schmid C.
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [Abstract] [Full Text] [Related]

  • 11. Chronic megakaryocytic-granulocytic myelosis--an electron microscopic study. I. Megakaryocytes and thrombocytes.
    Thiele J, Ballard AC, Georgii A, Vykoupil KF.
    Virchows Arch A Pathol Anat Histol; 1977 Apr 06; 373(3):191-211. PubMed ID: 140504
    [Abstract] [Full Text] [Related]

  • 12. Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.
    Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner G, Mahl G, Sund M.
    J Clin Pathol; 1986 Mar 06; 39(3):237-52. PubMed ID: 3457024
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases.
    Buss DH, O'Connor ML, Woodruff RD, Richards F, Brockschmidt JK.
    Arch Pathol Lab Med; 1991 May 06; 115(5):475-80. PubMed ID: 2021316
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M.
    Recenti Prog Med; 2003 May 06; 94(7-8):314-20. PubMed ID: 12868237
    [Abstract] [Full Text] [Related]

  • 15. Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.
    Medinger M, Tzankov A, Kern J, Pircher A, Hermann M, Ott HW, Gastl G, Untergasser G, Gunsilius E.
    Thromb Haemost; 2011 Jan 06; 105(1):72-80. PubMed ID: 20978717
    [Abstract] [Full Text] [Related]

  • 16. Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic findings and clinical course.
    Georgii A, Vykoupil KF, Thiele J.
    Bibl Haematol; 1984 Jan 06; (50):41-56. PubMed ID: 6590038
    [No Abstract] [Full Text] [Related]

  • 17. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I, Galatâr N.
    Morphol Embryol (Bucur); 1989 Jan 06; 35(2):117-27. PubMed ID: 2529429
    [Abstract] [Full Text] [Related]

  • 18. Chronic myeloproliferative disorders (CMPD).
    Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner G, Mahl G, Sund M.
    Pathol Res Pract; 1984 Nov 06; 179(2):131-86. PubMed ID: 6395125
    [Abstract] [Full Text] [Related]

  • 19. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP, Sanchez SR, Ewton AA, Rice L, Perkins SL, Dunphy CH, Chang CC.
    Hum Pathol; 2008 Oct 06; 39(10):1454-8. PubMed ID: 18619646
    [Abstract] [Full Text] [Related]

  • 20. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
    Campr V.
    Cesk Patol; 2011 Jul 06; 47(3):84-93. PubMed ID: 21887923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.